- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- OncNursingNews.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Bone Marrow & Stem Cell Transplant | Clinical
Challenges in Treating Myelofibrosis
May 17, 2022
Raajit Rampal, MD, PhD, discusses the challenges and unmet needs of myelofibrosis treatments and highlights promising investigational therapies.
Assessing Treatment Response in Myelofibrosis
May 17, 2022
Dr Raajit Rampal provides a brief overview of the criteria used to define response to myelofibrosis treatment.
Switching Between Therapies in Myelofibrosis
May 17, 2022
Dr Raajit Rampal discusses factors to consider when switching between therapies among patients with myelofibrosis.
Pacritinib in Myelofibrosis
May 17, 2022
Raajit Rampal, MD, PhD, reviews data from the PERSIST trials which support the use of pacritinib for myelofibrosis treatment.
Available Treatment Options for Myelofibrosis
May 17, 2022
An overview of the currently available treatment options in myelofibrosis.
Myelofibrosis and its Clinical Phenotypes
May 17, 2022
An explanation of the clinical phenotypes of myelofibrosis.
Myelofibrosis and the COMFORT Trials
May 17, 2022
Dr Raajit Rampal assesses whether frontline treatment with ruxolitinib was appropriate in the presented patient case with supporting data from the COMFORT-I and -II clinical trials.
Overview: A 67-Year-Old Man with Primary Myelofibrosis
May 17, 2022
Raajit Rampal, MD, PhD, reviews the case of a 67-year-old man with primary myelofibrosis and shares his initial impressions.
Benefits and Risks of Stem Cell Transplant for Older Patients With MDS
May 16, 2022
Ronald L. Paquette, MD, discusses the choice of using bone marrow and stem cell transplants as treatment for patients with myelodysplastic syndrome.
Stem Cell Transplant Holds its Position as Upfront Treatment for Hematologic Malignancies
May 10, 2022
In an interview with Targeted Oncology, Robert J. Soiffer, MD, discussed the evolving role of stem cell transplant in hematologic malignancies as CAR T-cell therapies begin to reshape treatment landscapes.